Correction: Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice
Alexandra Cambier, Jennifer Da Silva, Julie Bex, Fanny Canesi, Lison Lachize Neanne, Aurélie Sannier, Hélène Mathieu, Erwan Boedec, Amandine Badie, Renato C. Monteiro
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal Diseases and Glomerulopathies · PI3K/AKT/mTOR signaling in cancer · Renal Transplantation Outcomes and Treatments
The fifth author’s initials appear incorrectly in the citation. The correct citation is: Cambier A, Da Silva J, Bex J, Canesi F, Lachize Neanne L, Sannier A, et al. (2025) Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. PLoS One 20(10): e0318581. https://doi.org/10.1371/journal.pone.0318581.
A second affiliation for the fifth author is not indicated. Lison Lachize Neanne is also affiliated with: Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte-Justine, Montréal, Canada.
The reference list from the paper itself. Each links out to its DOI / PubMed record.